SEC Form 5 · accession 0001442757-15-000002
HERON THERAPEUTICS, INC. /DE/ · HRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Savitr Capital, LLC
Other
Period of report
Dec 31, 2014
Accepted (ET)
Feb 12, 2015 · 4:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818033
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Heron Therapeutics Common Stock | Mar 12, 2014 | S | 9,000 | $14.4677 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Mar 13, 2014 | S | 4,000 | $14.5693 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Mar 14, 2014 | S | 2,000 | $14.8562 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Mar 18, 2014 | S | 10,000 | $15.1757 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Mar 19, 2014 | S | 10,000 | $15.5307 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Mar 20, 2014 | S | 5,000 | $15.5801 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Mar 21, 2014 | S | 3,000 | $15.3038 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Mar 25, 2014 | S | 4,000 | $14.1001 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Mar 27, 2014 | S | 1,000 | $14.33 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Jun 24, 2014 | S | 19,147 | $12.8187 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Jul 3, 2014 | S | 3,300 | $12.4502 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Jul 25, 2014 | S | 3,000 | $9.0317 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Jul 29, 2014 | S | 4,000 | $9.097 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Jul 30, 2014 | S | 3,000 | $9.1967 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Jul 31, 2014 | S | 1,000 | $9.2848 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Sep 19, 2014 | S | 10 | $9.10 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Sep 24, 2014 | S | 1,000 | $8.55 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Sep 26, 2014 | S | 1,000 | $8.52 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Sep 30, 2014 | S | 1,000 | $8.4005 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Oct 24, 2014 | S | 1,000 | $7.42 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Dec 16, 2014 | S | 3,700 | $9.3573 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Dec 17, 2014 | S | 1,000 | $9.24 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Dec 19, 2014 | S | 1,000 | $9.33 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Dec 22, 2014 | S | 2,000 | $9.6515 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Dec 23, 2014 | S | 1,000 | $9.80 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | Sep 29, 2014 | S | 3,000 | $8.7653 | D | 1,712,366 | D | |
| Heron Therapeutics Common Stock | holding | — | — | — | 1,712,366 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F14